{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:23:19Z","timestamp":1787016199737,"version":"build-2736575974"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T00:00:00Z","timestamp":1468886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ISBT Science Series"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>\n                      Although interest in assessing risk of\n                      <jats:styled-content style=\"fixed-case\">TTI<\/jats:styled-content>\n                      s, very few trends in blood safety epidemiological data from resource\u2010limited blood services are reported in the literature. This analysis aims at reporting trends in seroprevalences of\n                      <jats:styled-content style=\"fixed-case\">TTI<\/jats:styled-content>\n                      s in blood donations in the Yaound\u00e9 University Teaching Hospital (\n                      <jats:styled-content style=\"fixed-case\">UTH<\/jats:styled-content>\n                      ) from 2011 to 2015 and to describe reasons for these changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      All donations of 2015 were tested for\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      1&amp;2 antibodies and the P24 antigen,\n                      <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>\n                      sAg,\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      antibody and the Treponema pallidum antibody. Screening for\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      uses a national algorithm based on the systematic use of two assays of different principles: a rapid determination testing assay and an\n                      <jats:styled-content style=\"fixed-case\">EIA HIV<\/jats:styled-content>\n                      1 &amp; 2 Ab\u2010Ag. The tests used for\n                      <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>\n                      sAg and\n                      <jats:styled-content style=\"fixed-case\">HCVA<\/jats:styled-content>\n                      b screening were all based on\n                      <jats:styled-content style=\"fixed-case\">EIA<\/jats:styled-content>\n                      techniques. Treponema pallidum antibody screening was based on Treponema Pallidum hemagglutination assay (\n                      <jats:styled-content style=\"fixed-case\">TPHA<\/jats:styled-content>\n                      ) and rapid immunochromatographic test (\n                      <jats:styled-content style=\"fixed-case\">RIT<\/jats:styled-content>\n                      ). Screening techniques and results from 2015 were compared to retrospective data from 2011, 2012, 2013 and 2014.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In 2015, 13\u00b74% (\n                      <jats:italic>n<\/jats:italic>\n                      = 214) of 1,596 blood donations were seropositive for at least one screened\n                      <jats:styled-content style=\"fixed-case\">TTI<\/jats:styled-content>\n                      s. The most frequent serological marker was\n                      <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>\n                      sAg with 123 (7\u00b77%) blood units contaminated. Nineteen (1\u00b72%) and 18 (1\u00b71%) blood units was positive for\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      and syphilis, respectively. There was a significant decrease in the total number of blood donations (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 10\n                      <jats:sup>\u22124<\/jats:sup>\n                      ) and\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>\n                      sAg and syphilis seroprevalences and an increase in the proportion of voluntary non\u2010remunerated blood donor (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0\u00b705).\n                      <jats:styled-content style=\"fixed-case\">HCVA<\/jats:styled-content>\n                      b seroprevalence was 3\u00b78% in 2015 and has not decreased significantly over the years (\n                      <jats:italic>P<\/jats:italic>\n                      = 0\u00b709).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Significant progress is noted in reduction in seroprevalences of\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      and syphilis since the beginning of a regular registration of data in 1990.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/voxs.12287","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T03:58:57Z","timestamp":1468900737000},"page":"82-87","source":"Crossref","is-referenced-by-count":9,"title":["Reducing risks of Transfusion\u2010transmitted infections in a resource\u2010limited hospital\u2010based blood bank: the case of the Yaound\u00e9 University Teaching Hospital, Cameroon"],"prefix":"10.1111","volume":"11","author":[{"given":"C. T.","family":"Tagny","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Biomedical Sciences of University of Yaound\u00e9 I Yaound\u00e9 Cameroon"},{"name":"Hematology &amp; Transfusion Service University Teaching Hospital Yaound\u00e9 Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ndoumba","sequence":"additional","affiliation":[{"name":"Hematology &amp; Transfusion Service University Teaching Hospital Yaound\u00e9 Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Laperche","sequence":"additional","affiliation":[{"name":"Institut National de la Transfusion Sanguine Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Blood System Research Institute San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mbanya","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biomedical Sciences of University of Yaound\u00e9 I Yaound\u00e9 Cameroon"},{"name":"Hematology &amp; Transfusion Service University Teaching Hospital Yaound\u00e9 Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"49","article-title":"S\u00e9rologie HIV et portage de l'antig\u00e8ne HBs et Hbe chez les donneurs de sang au CHU de Yaound\u00e9. Cameroun","volume":"70","author":"Zekeng L","year":"1990","journal-title":"Ann Soc Belg Med Trop"},{"key":"e_1_2_6_3_1","first-page":"613","article-title":"Progress toward prevention of transfusion\u2010transmitted hepatitis B and hepatitis C infection\u2013sub\u2010Saharan Africa, 2000\u20132011","volume":"63","author":"Apata IW","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_4_1","unstructured":"Institut National de la Statistique:Enqu\u00eate D\u00e9mographique et de Sant\u00e9 du Cameroun. Minist\u00e8re de l'administration territoriale Yaound\u00e9 Cameroun 2004"},{"key":"e_1_2_6_5_1","unstructured":"Comit\u00e9 National de Lutte contre le Sida:Profil des Estimations et projections en mati\u00e8re de VIH\/sida au Cameroun. Minist\u00e8re de la Sante Publique Yaound\u00e9 Cameroun 2012"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2005.00608.x"},{"key":"e_1_2_6_7_1","volume-title":"Statistical Methods in Medical Research","author":"Armitage P","year":"1987"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.042309"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(01)90028-1"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2003.00453.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02137.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02886.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02782.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2015.11.003"},{"key":"e_1_2_6_15_1","unstructured":"TapkoJB ToureB SamboLG:Status of blood safety in the WHO African Region: report of the 2010 survey. AFRO WHO Brazzaville 2014."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.11.005"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03391.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2006.06.002"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0958-7578.2004.00474.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2014.01.002"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03797.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/1117-1936.181405","article-title":"Improving supply of safe blood and reducing cost of transfusion service through haemovigilance","volume":"16","author":"Arewa OP","year":"2009","journal-title":"Niger Postgrad Med J"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2006.03.015"},{"key":"e_1_2_6_24_1","unstructured":"Safe Blood for Africa Foundation.Training in blood safety in Cameroon. Training plan: 2014\u20102018.The Safe Blood for Africa Foundation\u2122 Rivonia South Africa 2014"}],"container-title":["ISBT Science Series"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvoxs.12287","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/voxs.12287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T13:57:57Z","timestamp":1696168677000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/voxs.12287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1111\/voxs.12287"],"URL":"https:\/\/doi.org\/10.1111\/voxs.12287","archive":["Portico"],"relation":{},"ISSN":["1751-2816","1751-2824"],"issn-type":[{"value":"1751-2816","type":"print"},{"value":"1751-2824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}